Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) CEO Thomas J. Shaw purchased 18,226 shares of the firm’s stock in a transaction on Friday, January 10th. The shares were acquired at an average cost of $0.73 per share, for a total transaction of $13,304.98. Following the completion of the purchase, the chief executive officer now directly owns 14,966,204 shares of the company’s stock, valued at approximately $10,925,328.92. This represents a 0.12 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Retractable Technologies Trading Up 2.0 %
NYSE RVP opened at $0.75 on Tuesday. The firm has a market cap of $22.60 million, a PE ratio of -1.40 and a beta of 1.94. Retractable Technologies, Inc. has a 1-year low of $0.56 and a 1-year high of $1.34. The stock has a 50-day moving average of $0.66 and a 200-day moving average of $0.84. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01.
Analyst Ratings Changes
Separately, StockNews.com assumed coverage on shares of Retractable Technologies in a research report on Tuesday. They issued a “hold” rating on the stock.
Institutional Trading of Retractable Technologies
An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC purchased a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP – Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 7.58% of the company’s stock.
About Retractable Technologies
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Featured Articles
- Five stocks we like better than Retractable Technologies
- How to Calculate Options Profits
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Investing In Preferred Stock vs. Common Stock
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.